Back to Results
First PageMeta Content
Health / Bromelain / Inflammation / Proteases / Antioxidant / Interleukin 6 / Interleukin-1 receptor / Atherosclerosis / Biology / Medicine / Physiology


An upper limit for macromolecular crowding effects
Add to Reading List

Open Document

File Size: 301,39 KB

Share Result on Facebook

City

Helsinki / Berlin / Munich / Bonn / /

Company

LG / Ogden / MUCOS GmbH / Google / Hale LP / Jones SA / HP / Creative Commons / MUCOS Pharma GmbH & Co. KG / BioMed Central Ltd. / SPSS / Vinci / Human Performance Laboratory / /

Country

Germany / United States / /

/

Event

Funding / /

Facility

Humboldt University / Appalachian State University / Carolina Research Campus / /

IndustryTerm

cancer prevention / treatment for diabetes / fatty food / study protocol / trial protocol / lipoxygenase products / polyphenol-rich beverage / online plausibility checks / valid tool / partner site / investigational product / treatment of osteoarthritis / study product / scientific protocol / online submission / /

MedicalCondition

inflammatory response / inflammatory perturbations / Very few allergic reactions / marathon-induced inflammation / JE / post marathon inflammation / common cold / strain / arterial hypertension / allergic respiratory diseases / heavy inflammatory illnesses / chronic renal failure / exercise-induced inflammation / Known allergy / painful osteoarthritis / inflammatory markers / rheumatologic disease / injury / low-grade systemic inflammation / Chronic exercise / medications influencing inflammation / marathon-induced immune dysfunction / diarrhea / inflammatory stimulus / sinusitis / immunologically mediated atherosclerosis / illness / reduced atherosclerosis / allergic respiratory disease / inflammatory diseases / sepsis / upper respiratory tract infection / ischemia/reperfusion injury / intercurrent illness / thrombophlebitis / immune dysfunction / cancer / burn / atherosclerosis / inflammatory drugs / chronic liver disease / acute inflammation / rheumatic diseases / Infectious episodes / respiratory tract illness / cardiovascular disease / allograft arteriosclerosis / osteoarthritis / pain / myocardial infarction / diabetes mellitus / ischemiareperfusion injury / psychiatric disease / visits inflammation / cardiac disease / lactose intolerance / chronic diseases / inflammatory disease / thrombus / future myocardial infarction / e.g. leukocytosis / chronic infection / inflammation / acute sinusitis / injuries / inflammatory / inflammatory parameters / upper respiratory tract infections / /

Organization

World Health Organization / Munich Heart Alliance / Institute for Clinical Pharmacology / Department of Prevention / Rehabilitation and Sports Medicine / Humboldt University Berlin / Appalachian State University / Department of Prevention / German Centre for Cardiovascular Research / /

Person

Van Cott / /

Position

investigator / principal investigator / Mundt MP / author / Ridker PM / Bertoni MP / central mediator / /

Product

Wobenzym tablets / /

RadioStation

Petersen AM / /

Technology

study protocol / 1/8 STUDY PROTOCOL / Sports Medicine / firewall system / trial protocol / html / scientific protocol / /

URL

www.biomedcentral.com/submit / http /

SocialTag